‌

US Patent 11673972 Heterodimeric antibodies that bind CD3 and tumor antigens

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

June 13, 2023

0

Patent Application Number

171243710

Date Filed

December 16, 2020

0

Patent Citations

US Patent 7276497 Cytotoxic agents comprising new maytansinoids

0

US Patent 7303749 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents

0

US Patent 7368565 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents

0

US Patent 7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor

0

US Patent 7517903 Cytotoxic compounds and conjugates

0

US Patent 7601354 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents

0

US Patent 7695936 Knobs and holes heteromeric polypeptides

0

US Patent 7696338 Immunotoxin fusion proteins and means for expression thereof

0

...

Patent Primary Examiner

0

CPC Code

0

The present invention is directed to novel heterodimeric antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11673972 Heterodimeric antibodies that bind CD3 and tumor antigens

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.